These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 17003332)

  • 1. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase.
    Carey AL; Steinberg GR; Macaulay SL; Thomas WG; Holmes AG; Ramm G; Prelovsek O; Hohnen-Behrens C; Watt MJ; James DE; Kemp BE; Pedersen BK; Febbraio MA
    Diabetes; 2006 Oct; 55(10):2688-97. PubMed ID: 17003332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes.
    Yamaguchi S; Katahira H; Ozawa S; Nakamichi Y; Tanaka T; Shimoyama T; Takahashi K; Yoshimoto K; Imaizumi MO; Nagamatsu S; Ishida H
    Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E643-9. PubMed ID: 15928020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes.
    Gaidhu MP; Fediuc S; Ceddia RB
    J Biol Chem; 2006 Sep; 281(36):25956-64. PubMed ID: 16816404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.
    Al-Khalili L; Bouzakri K; Glund S; Lönnqvist F; Koistinen HA; Krook A
    Mol Endocrinol; 2006 Dec; 20(12):3364-75. PubMed ID: 16945991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The AMP-activated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake and p38 mitogen-activated protein kinases alpha and beta in skeletal muscle.
    Lemieux K; Konrad D; Klip A; Marette A
    FASEB J; 2003 Sep; 17(12):1658-65. PubMed ID: 12958172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR.
    Russell RR; Bergeron R; Shulman GI; Young LH
    Am J Physiol; 1999 Aug; 277(2):H643-9. PubMed ID: 10444490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of AMP-activated protein kinase and p38 mitogen-activated protein kinase signaling in skeletal muscle.
    Ho RC; Fujii N; Witters LA; Hirshman MF; Goodyear LJ
    Biochem Biophys Res Commun; 2007 Oct; 362(2):354-9. PubMed ID: 17709097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes.
    Sakoda H; Ogihara T; Anai M; Fujishiro M; Ono H; Onishi Y; Katagiri H; Abe M; Fukushima Y; Shojima N; Inukai K; Kikuchi M; Oka Y; Asano T
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1239-44. PubMed ID: 12006353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMP-activated protein kinase activation by AICAR increases both muscle fatty acid and glucose uptake in white muscle of insulin-resistant rats in vivo.
    Iglesias MA; Furler SM; Cooney GJ; Kraegen EW; Ye JM
    Diabetes; 2004 Jul; 53(7):1649-54. PubMed ID: 15220186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle.
    Li J; Hu X; Selvakumar P; Russell RR; Cushman SW; Holman GD; Young LH
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E834-41. PubMed ID: 15265762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway.
    Tan MJ; Ye JM; Turner N; Hohnen-Behrens C; Ke CQ; Tang CP; Chen T; Weiss HC; Gesing ER; Rowland A; James DE; Ye Y
    Chem Biol; 2008 Mar; 15(3):263-73. PubMed ID: 18355726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term AMP-regulated protein kinase activation enhances insulin-sensitive fatty acid uptake and increases the effects of insulin on fatty acid oxidation in L6 muscle cells.
    Kelly KR; Abbott MJ; Turcotte LP
    Exp Biol Med (Maywood); 2010 Apr; 235(4):514-21. PubMed ID: 20407084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMP-activated protein kinase: possible target for treatment of type 2 diabetes.
    Winder WW
    Diabetes Technol Ther; 2000; 2(3):441-8. PubMed ID: 11467346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone treatment enhances acute AMP-activated protein kinase-mediated muscle and adipose tissue glucose uptake in high-fat-fed rats.
    Ye JM; Dzamko N; Hoy AJ; Iglesias MA; Kemp B; Kraegen E
    Diabetes; 2006 Oct; 55(10):2797-804. PubMed ID: 17003345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging impairs insulin-stimulated glucose uptake in rat skeletal muscle via suppressing AMPKalpha.
    Qiang W; Weiqiang K; Qing Z; Pengju Z; Yi L
    Exp Mol Med; 2007 Aug; 39(4):535-43. PubMed ID: 17934342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation.
    Jørgensen SB; Honeyman J; Oakhill JS; Fazakerley D; Stöckli J; Kemp BE; Steinberg GR
    Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E57-66. PubMed ID: 19435854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α2 isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle.
    Nakano M; Hamada T; Hayashi T; Yonemitsu S; Miyamoto L; Toyoda T; Tanaka S; Masuzaki H; Ebihara K; Ogawa Y; Hosoda K; Inoue G; Yoshimasa Y; Otaka A; Fushiki T; Nakao K
    Metabolism; 2006 Mar; 55(3):300-8. PubMed ID: 16483872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes-Related Ankyrin Repeat Protein (DARP/Ankrd23) Modifies Glucose Homeostasis by Modulating AMPK Activity in Skeletal Muscle.
    Shimoda Y; Matsuo K; Kitamura Y; Ono K; Ueyama T; Matoba S; Yamada H; Wu T; Chen J; Emoto N; Ikeda K
    PLoS One; 2015; 10(9):e0138624. PubMed ID: 26398569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AICAR and hyperosmotic stress increase insulin-stimulated glucose transport.
    Smith JL; Patil PB; Fisher JS
    J Appl Physiol (1985); 2005 Sep; 99(3):877-83. PubMed ID: 15860681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior serum- and AICAR-induced AMPK activation in primary human myocytes does not lead to subsequent increase in insulin-stimulated glucose uptake.
    Al-Khalili L; Krook A; Zierath JR; Cartee GD
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E553-7. PubMed ID: 15149951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.